| Trademark Snap Shot Publication & Issue Review Stylesheet (Table presents the data on Publication & Issue Review Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 79055263 | FILING DATE | 12/20/2007 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | 0968271 | INTL REG DATE | 12/20/2007 |
| TM ATTORNEY | PHAM, LANA H |
L.O. ASSIGNED | 115 |
PUB INFORMATION |
|||
| RUN DATE | 11/11/2009 | ||
| PUB DATE | 12/15/2009 | ||
| STATUS | 681-PUBLICATION/ISSUE REVIEW COMPLETE | ||
| STATUS DATE | 11/10/2009 | ||
| LITERAL MARK ELEMENT | HIPERFECT | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | YES | 66A | YES | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | HIPERFECT |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | QIAGEN GmbH |
| ADDRESS | Qiagen Strasse 1 40724 Hilden |
| ENTITY | 99-limited liability company |
| CITIZENSHIP | Germany |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, nucleic acids for laboratory and laboratory research use, enzymes, polymerases, chemical and biochemical reagents for staining and marking for laboratory and research use, chemical and biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleic acid arrays, transfection reagents for research purposes, anionic, cationic and zwitterionic lipids and mixtures thereof for introducing chemical, biochemical and biotechnological products into cells, chemical buffers used in analytical chemistry and biochemistry, aqueous and non-aqueous solutions of alcohols and/or salts, namely, solutions containing isopropanol, ethanol, methanol, propanol, butanol or PEG and solutions containing chaotropic salts, distilled water, column and membrane material comprising silicium dioxide for the isolation, purification or separation of chemical, biochemical and biotechnological products, none of the foregoing for medical or veterinary purposes; chemicals and biochemicals for industrial and scientific purposes, namely, reagents for research purposes for industrial and commercial use for sample preparation, purification, lysis, modification and manipulation of cells and tissues, namely, transfection chemical reagents for non-medical purposes, chemical reagents for non-medical purposes and aromatic solvents for industrial and commercial use for performing marking, separating, isolating, purification, amplification, and/or analysis methods of biopolymers, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances for separation, modification, analysis, marking, amplification and purification of biological and chemical compounds, none of the foregoing for medical or veterinary purposes; kits comprising chemical preparations for scientific and chemicals for industrial purposes, kits comprising biochemicals for scientific or industrial purposes and kits comprising biotechnological products for scientific purposes, namely, biochemical catalysts, transfection chemical reagents for non-medical purposes, anionic, cationic and zwitterionic lipids and mixtures thereof for introducing chemical, biochemical and biotechnological products into cells, nucleic acids for laboratory use, oligonucleotides for scientific research, enzymes for scientific and research purposes, proteins for scientific research, chemical and biochemical reagents for staining and marking for non-medical purposes, chemical and biochemical reagents commonly known as probes for detecting and analysing molecules in protein or nucleic acid arrays and/or comprising chemical buffers for industrial and commercial use for sample preparation, purification, lysis, modification and manipulation of cells or tissue and for performing marking, separating, isolating, purification, amplification and/or analysis methods for biopolymers, namely, nucleic acids, enzymes, proteins, macromolecules, none of the foregoing for medical or veterinary purposes |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Diagnostic preparations for medical and veterinary purposes; pharmaceutical and veterinary products, namely, nucleic acid sequences, chemical reagents and biochemical preparations for medical or veterinary purposes; nucleic acid sequences for diagnostic and/or pharmaceutical purposes; anionic, cationic and zwitterionic lipids and mixtures thereof for the introduction of molecules into cells for diagnostic and/or pharmaceutical purposes; medical or diagnostic transfection reagents for diagnostic and/or pharmaceutical purposes; kits comprising chemical reagents for medical and veterinary-diagnostic purposes, kits comprising biochemical preparations for medical and veterinary-diagnostic purposes and kits comprising biotechnological products, namely, transfection reagents, anionic, cationic and zwitterionic lipids and mixtures thereof for the introduction of molecules into cells, all of the foregoing for medical, veterinary and/or diagnostic purposes |
| INTERNATIONAL CLASS | 009 |
| DESCRIPTION TEXT | Scientific apparatuses, instruments and equipment and laboratory instruments and measuring apparatuses and instruments in particular for research, medical, diagnostic and analysis purposes, namely, disposable laboratory articles, namely, plastic vessels, sample storage vessels, reaction and collection vessels and plates, multi-well plates, tips, including filter tips and dispenser tips, pipette tips and tip boxes, tubes, microtubes and tubes for PCR and micro centrifuges and micro-injection, capillaries, curvettes, spin columns, cartridges and columns filed with chromatographic material for the separation, purification, and isolation of biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material, in particular nucleic acids from biological or biochemical sample material, in particular for transfection, racks and holders for samples storage vessels, tubes, syringes and tips; sample presentation devices, mircroarrays, chips, MALDI-MS presentation devices; laboratory robots, robotic workstations and systems and laboratory incubators for diagnostic, clinical and research applications for the preparation, modification, isolation, crystallization, handling, amplification and manipulation of samples and for the transfecting, marking, separation, isolation, purification, reproduction and analysis of biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material, in particular nucleic acids from biological or biochemical sample material, laboratory apparatuses and equipment for dosage, dispensing, transferring, temperature equalizing, agitating, mixing, diluting, concentrating, transfecting and separating of liquids, MALDI- apparatuses, workstations for reading and handling multi-well plates for the analysis of biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material in particular nucleic acids from biological or biochemical sample material, in particular for nucleic acid amplification, in particular by polymerase chain reaction (PCR); laboratory equipment, namely, cyclers, thermocyclers, lysis apparatuses, disrupters, physico-chemical, bio-chemical, optical and electronic analysis apparatus and equipment, in particular photometers, spectrophotometers, optical scanners for detection of fluorescence and colorimetric signals; apparatuses for processing cells or liquids containing cells in particular electroporators, electrofusion apparatuses, micro injectors and micro manipulators; vacuum chambers for chromatography, purification, separation and characterization of natural and synthetic biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material; centrifuges; vacuum systems for laboratory use, vacuum concentrators; centrifugal concentrators; rotors for laboratory centrifuges and vacuum concentrators, mixers; mechanical, electronical and automatical pipettes and dispensers for dispensing liquid for laboratory research and analysis purposes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 009 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| PSEUDO MARK | HI PERFECT; HIGH PERFECT |
SECTION 66A INTERNATIONAL REGISTRATION DATA |
|
| INTL REG # | 0968271 |
| INTL REG DATE | 12/20/2007 |
| PRIORITY CLMD | YES |
| PRIOR CLMD DATE | 07/04/2007 |
| INTL STATUS | 001-REQUEST FOR EXTENSION OF PROTECTION PROCESSED |
| INTL STATUS DATE | 07/24/2008 |
| AUTO PROTECTION DATE | 07/22/2010 |
| INTL RENEWAL DATE | 12/20/2017 |
| INTL REG DEATH DATE | N/A |
| FIRST REFUSAL | YES |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 11/10/2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 034 |
| 11/07/2009 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 033 |
| 10/27/2009 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 032 |
| 10/27/2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 031 |
| 10/22/2009 | ALIE | A | ASSIGNED TO LIE | 030 |
| 10/13/2009 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | 029 |
| 10/13/2009 | EXPI | T | EX PARTE APPEAL-INSTITUTED | 028 |
| 10/13/2009 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | 027 |
| 10/13/2009 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | 026 |
| 06/29/2009 | LIMN | I | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | 025 |
| 06/19/2009 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | 024 |
| 06/11/2009 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | 023 |
| 04/13/2009 | GNS1 | O | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | 022 |
| 04/13/2009 | GNSF | O | SUBSEQUENT FINAL EMAILED | 021 |
| 04/13/2009 | CFRC | R | SUBSEQUENT FINAL REFUSAL WRITTEN | 020 |
| 03/09/2009 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 019 |
| 02/06/2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 018 |
| 03/09/2009 | ATRV | O | ATTORNEY REVIEW COMPLETED | 017 |
| 03/09/2009 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | 016 |
| 03/09/2009 | GNFR | O | FINAL REFUSAL E-MAILED | 015 |
| 03/09/2009 | CNFR | R | FINAL REFUSAL WRITTEN | 014 |
| 02/09/2009 | CREV | I | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | 013 |
| 02/06/2009 | ARAA | I | ATTORNEY REVOKED AND/OR APPOINTED | 012 |
| 02/06/2009 | REAP | I | TEAS REVOKE/APPOINT ATTORNEY RECEIVED | 011 |
| 02/06/2009 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 010 |
| 01/22/2009 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | 009 |
| 08/22/2008 | RFNP | P | REFUSAL PROCESSED BY IB | 008 |
| 08/07/2008 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 007 |
| 08/07/2008 | RFRR | P | REFUSAL PROCESSED BY MPU | 006 |
| 08/07/2008 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 005 |
| 08/06/2008 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 07/25/2008 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 07/25/2008 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 002 |
| 07/24/2008 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Gary D. Krugman |
| CORRESPONDENCE ADDRESS | Gary D. Krugman Sughrue Mion, PLLC 2100 Pennsylvania Avenue, NW Washington DC 20037 |
| DOMESTIC REPRESENTATIVE | Gary D. Krugman |